help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 68, No. 4 851-854
doi:10.1210/jcem-68-4-851
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ABE, J.
Right arrow Articles by KUROKI, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ABE, J.
Right arrow Articles by KUROKI, T.

Resistance to 1,25-Dihydroxyvitamin D3 of Cultured Psoriatic Epidermal Keratinocytes Isolated from Involved and Uninvolved Skin*

JUNKO ABE, SEIJI KONDO, YASUHO NISHII and TOSHIO KUROKI

Research Laboratories, Chugai Pharmaceutical Co., Ltd. (J.A., Y.N.) Takada, Toshima-ku, Tokyo 171
The Department of Dermatology, School of Medicine, Tokyo Medical and Dental University (S.K.) Yushima, Bunkyo-ku, Tokyo 113
The Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo (T.K.) Shirokanedai, Minato-ku, Tokyo 108, Japan

Address all correspondence and requests for reprints to: Toshio Kuroki, M.D., Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108, Japan.

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3], a hormonally active form of vitamin D3, has been reported to stimulate epidermal differentiation and to be an effective treatment of psoriatic lesions. We studied the responsiveness of psoriatic epidermal keratinocytes to 1,25-(OH)2D3 in explantoutgrowth cultures of involved and uninvolved skin from six patients with psoriasis. A feeder layer was required for outgrowth of psoriatic epidermal keratinocytes of involved skin, but not for that of cells of uninvolved skin. The growth of normal epidermal keratinocytes was inhibited by 1,25-(OH)2D3, and the number of DNA-synthesizing cells, determined in autoradiographs, was reduced to about 15% of that in control cultures by 1 nmol/L 1,25-(OH)2D3 (0.4 ng/mL).

Epidermal keratinocytes isolated from both involved and uninvolved skin of patients with psoriasis were resistant, and 100-fold more 1,25-(OH)2D3 was required to inhibit their DNA synthesis. These results afford new insight into the etiology and therapy of psoriasis.

* This work was supported in part by Grant-in-Aid for Special Project Research, Cancer-Bioscience, from the Ministry of Education, Science and Culture, Japan.

Received August 8, 1988.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. Zehnder, R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison
Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 888 - 894.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society